Skip to main content
Browse by:
GROUP

Pathology Grand Rounds - New Perspectives on RAS Signaling in Cancer

Event Image
Friday, October 29, 2021
12:00 pm - 1:00 pm
Edward Stites, MD, PhD, Salk Institute for Biological Studies
Pathology Grand Rounds

At the conclusion of this activity, learners should be able to:

* Describe clinical trial data showing variation in how RAS mutant cancers respond to treatment

* Describe ongoing studies subclassifying RAS mutants into those that are biomarkers for EGFR inhibitor sensitivity and for EGFR inhibitor resistance

* Identify computational simulations as an emerging computational tool for studying pathogenic mutations and their response to treatment

Type: LECTURE/TALK